Cargando…
Computational Modeling of Catecholamines Dysfunction in Alzheimer’s Disease at Pre-Plaque Stage
BACKGROUND: Alzheimer’s disease (AD) etiopathogenesis remains partially unexplained. The main conceptual framework used to study AD is the Amyloid Cascade Hypothesis, although the failure of recent clinical experimentation seems to reduce its potential in AD research. OBJECTIVE: A possible explanati...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592658/ https://www.ncbi.nlm.nih.gov/pubmed/32741822 http://dx.doi.org/10.3233/JAD-200276 |
_version_ | 1783601230073823232 |
---|---|
author | Caligiore, Daniele Silvetti, Massimo D’Amelio, Marcello Puglisi-Allegra, Stefano Baldassarre, Gianluca |
author_facet | Caligiore, Daniele Silvetti, Massimo D’Amelio, Marcello Puglisi-Allegra, Stefano Baldassarre, Gianluca |
author_sort | Caligiore, Daniele |
collection | PubMed |
description | BACKGROUND: Alzheimer’s disease (AD) etiopathogenesis remains partially unexplained. The main conceptual framework used to study AD is the Amyloid Cascade Hypothesis, although the failure of recent clinical experimentation seems to reduce its potential in AD research. OBJECTIVE: A possible explanation for the failure of clinical trials is that they are set too late in AD progression. Recent studies suggest that the ventral tegmental area (VTA) degeneration could be one of the first events occurring in AD progression (pre-plaque stage). METHODS: Here we investigate this hypothesis through a computational model and computer simulations validated with behavioral and neural data from patients. RESULTS: We show that VTA degeneration might lead to system-level adjustments of catecholamine release, triggering a sequence of events leading to relevant clinical and pathological signs of AD. These changes consist first in a midfrontal-driven compensatory hyperactivation of both VTA and locus coeruleus (norepinephrine) followed, with the progression of the VTA impairment, by a downregulation of catecholamine release. These processes could then trigger the neural degeneration at the cortical and hippocampal levels, due to the chronic loss of the neuroprotective role of norepinephrine. CONCLUSION: Our novel hypothesis might contribute to the formulation of a wider system-level view of AD which might help to devise early diagnostic and therapeutic interventions. |
format | Online Article Text |
id | pubmed-7592658 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | IOS Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-75926582020-10-30 Computational Modeling of Catecholamines Dysfunction in Alzheimer’s Disease at Pre-Plaque Stage Caligiore, Daniele Silvetti, Massimo D’Amelio, Marcello Puglisi-Allegra, Stefano Baldassarre, Gianluca J Alzheimers Dis Research Article BACKGROUND: Alzheimer’s disease (AD) etiopathogenesis remains partially unexplained. The main conceptual framework used to study AD is the Amyloid Cascade Hypothesis, although the failure of recent clinical experimentation seems to reduce its potential in AD research. OBJECTIVE: A possible explanation for the failure of clinical trials is that they are set too late in AD progression. Recent studies suggest that the ventral tegmental area (VTA) degeneration could be one of the first events occurring in AD progression (pre-plaque stage). METHODS: Here we investigate this hypothesis through a computational model and computer simulations validated with behavioral and neural data from patients. RESULTS: We show that VTA degeneration might lead to system-level adjustments of catecholamine release, triggering a sequence of events leading to relevant clinical and pathological signs of AD. These changes consist first in a midfrontal-driven compensatory hyperactivation of both VTA and locus coeruleus (norepinephrine) followed, with the progression of the VTA impairment, by a downregulation of catecholamine release. These processes could then trigger the neural degeneration at the cortical and hippocampal levels, due to the chronic loss of the neuroprotective role of norepinephrine. CONCLUSION: Our novel hypothesis might contribute to the formulation of a wider system-level view of AD which might help to devise early diagnostic and therapeutic interventions. IOS Press 2020-09-01 /pmc/articles/PMC7592658/ /pubmed/32741822 http://dx.doi.org/10.3233/JAD-200276 Text en © 2020 – IOS Press and the authors. All rights reserved https://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC 4.0) License (https://creativecommons.org/licenses/by-nc/4.0/) , which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Caligiore, Daniele Silvetti, Massimo D’Amelio, Marcello Puglisi-Allegra, Stefano Baldassarre, Gianluca Computational Modeling of Catecholamines Dysfunction in Alzheimer’s Disease at Pre-Plaque Stage |
title | Computational Modeling of Catecholamines Dysfunction in Alzheimer’s Disease at Pre-Plaque Stage |
title_full | Computational Modeling of Catecholamines Dysfunction in Alzheimer’s Disease at Pre-Plaque Stage |
title_fullStr | Computational Modeling of Catecholamines Dysfunction in Alzheimer’s Disease at Pre-Plaque Stage |
title_full_unstemmed | Computational Modeling of Catecholamines Dysfunction in Alzheimer’s Disease at Pre-Plaque Stage |
title_short | Computational Modeling of Catecholamines Dysfunction in Alzheimer’s Disease at Pre-Plaque Stage |
title_sort | computational modeling of catecholamines dysfunction in alzheimer’s disease at pre-plaque stage |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592658/ https://www.ncbi.nlm.nih.gov/pubmed/32741822 http://dx.doi.org/10.3233/JAD-200276 |
work_keys_str_mv | AT caligioredaniele computationalmodelingofcatecholaminesdysfunctioninalzheimersdiseaseatpreplaquestage AT silvettimassimo computationalmodelingofcatecholaminesdysfunctioninalzheimersdiseaseatpreplaquestage AT dameliomarcello computationalmodelingofcatecholaminesdysfunctioninalzheimersdiseaseatpreplaquestage AT puglisiallegrastefano computationalmodelingofcatecholaminesdysfunctioninalzheimersdiseaseatpreplaquestage AT baldassarregianluca computationalmodelingofcatecholaminesdysfunctioninalzheimersdiseaseatpreplaquestage |